tact2.org
Information for Clinical Sites - Tact2
http://www.tact2.org/information-clinical-sites
Information for Clinical Sites. Information for Clinical Sites. We Are Currently Accepting New Sites! For more information about becoming a site for the TACT2 trial. We have identified more than 100 clinical sites in the United States and Canada that wish to participate in TACT2 and continue to accept new site applications. Or contact us for more information. About becoming a clinical site. Sites Participating in TACT2. Gervasio Lamas, MD. Kevin Anstrom, PhD. Daniel Mark, MD, MPH. Miami Beach, FL 33140.
tact2.org
About Us - Tact2
http://www.tact2.org/about-us
Who is leading TACT2? Gervasio Lamas, MD. Principal Investigator, Clinical Coordinating Center. Kevin Anstrom, PhD. Co-PI, Data Coordinating Center. Daniel B. Mark, MD, MPH. Co-PI, Data Coordinating Center. Esteban Escolar, MD. Associate Director, CCC. Jonathan Newman, MD. Associate Director, CCC. Patricia Cowper, PhD. Kerry L. Lee, PhD. Gervasio Lamas, MD. Kevin Anstrom, PhD. Daniel Mark, MD, MPH. Mount Sinai Medical Center. 4300 Alton Road, Suite 2070A. Miami Beach, FL 33140. Durham NC, 27705.
tact2.org
Scientific Publications - Tact2
http://www.tact2.org/publications
Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy. November 7, 2016. Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy. May 18, 2016. Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider? April 18, 2016. Enhanced Vasculotoxic Metal Excretion in Post-Myocardial Infarction Patients Receiving Edetate Disodium-Based Infusion. April 5, 2016. Chelation Therapy for CAD.
tact2.org
In the News - Tact2
http://www.tact2.org/news
TACTful Perseverance and a Black Swan Event. Tactful Perseverance and a Black Swan Event TACT2 to follow-up on post-MI diabetic patients. “I have to admit that until 1999, I had no particular interest in studying a pariah therapy called EDTA chelation really just not my style.” / “When the Duke staff distributed the previously blinded analyses, all of us turned to the bottom line, . more. Treatment might help prevent second heart attack for people with diabetes. Chelation, A Potentially Lifesaving Therapy.
tact2.org
Information for Patients - Tact2
http://www.tact2.org/information-for-patients
TACT2 will enroll about 1200 patients in the U.S. and Canada who are 50 years of age or older, have had a heart attack, have diabetes, and meet other eligibility criteria. Click on a map marker to see more information about the sites that are participating in TACT2. View TACT2 Clinical Sites. In a full screen map. Where can I learn more about TACT2? Learn more about the study at clinicaltrials.gov. Learn more about chelation therapy. Learn more about the TACT studies. Gervasio Lamas, MD. Durham NC, 27705.
tact2.org
About the TACT Studies - Tact2
http://www.tact2.org/about-the-tact-studies
About the TACT Studies. About the TACT Studies. Brief History and Overview. Chelation is the administration of chelating agents to remove heavy metals from the body. Chelation treatment was first reported to have clinical benefits in patients with symptomatic coronary artery disease (CAD) through a serendipitous set of observations starting in 1956. Subsequent clinical investigations of chelation, however, were mixed and serious research in this area stopped in the early 1960s. NHLBI). At the time, m...
tact2.org
Español - Tact2
http://www.tact2.org/espanol
Remover los metales tóxicos de la sangre ayuda a los diabéticos. Http:/ www.elnuevoherald.com/vivir-mejor/salud/article116993768.html more. Ensayo clínico busca beneficios en pacientes diabéticos. 9/29/2016 – The National Center for Complementary and Integrative Health (NCCIH) que forma parte de los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) ha otorgado $37M a . more. Riesgos de metales pesados a los que estamos expuestos y no sabemos. La quelación intravenosa, alternativa del futuro?
